Y-box Binding Protein-1, a Potential Target in Malignant Pleural Mesothelioma, Drives Growth Through Distinct Mechanisms

被引：0
|
作者：
Johnson, T. [1 ]
Schelch, K. [2 ]
Williams, M. [1 ]
Cheng, Y. Y. [1 ]
Grusch, M. [2 ]
Reid, G. [3 ]
Burgess, A. [4 ]
机构：
[1] Asbestos Dis Res Inst, Concord, NSW, Australia
[2] Med Univ Vienna, Inst Canc Res, Vienna, Austria
[3] Univ Otago, Dunedin, New Zealand
[4] Anzac Res Inst, Sydney, NSW, Australia
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
Mesothelioma; therapeutic target; cell cycle and apoptosis;
D O I：
10.1016/j.jtho.2019.08.1624
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.06-06
引用
收藏
页码：S757 / S757
页数：1
相关论文
共 50 条
  • [31] Overexpression of Y-box binding protein-1 in cervical cancer and its association with the pathological response rate to chemoradiotherapy
    Zhang, Y.
    Reng, S. R.
    Wang, L.
    Lu, L.
    Zhao, Z. H.
    Zhang, Z. K.
    Feng, X. D.
    Ding, X. D.
    Wang, J.
    Feng, G.
    Dai, T. Z.
    Pu, J.
    Du, X. B.
    MEDICAL ONCOLOGY, 2012, 29 (03) : 1992 - 1997
  • [32] Overexpression of Y-box binding protein-1 in cervical cancer and its association with the pathological response rate to chemoradiotherapy
    Y. Zhang
    S. R. Reng
    L. Wang
    L. Lu
    Z. H. Zhao
    Z. K. Zhang
    X. D. Feng
    X. D. Ding
    J. Wang
    G. Feng
    T. Z. Dai
    J. Pu
    X. B. Du
    Medical Oncology, 2012, 29 : 1992 - 1997
  • [33] Y-Box Binding Protein 1: Unraveling the Multifaceted Role in Cancer Development and Therapeutic Potential
    Dinh, Ngoc Thi Minh
    Nguyen, Tuan Minh
    Park, Mi Kyung
    Lee, Chang Hoon
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (02)
  • [34] Y-box binding protein-1 promotes tumorigenesis and progression via the epidermal growth factor receptor/AKT pathway in spinal chordoma
    Liang, Chen
    Ma, Yunlong
    Yong, Lei
    Yang, Chenlong
    Wang, Peng
    Liu, Xiao
    Zhu, Bin
    Zhou, Hua
    Liu, Xiaoguang
    Liu, Zhongjun
    CANCER SCIENCE, 2019, 110 (01): : 166 - 179
  • [35] Trilayer micelles for combination delivery of rapamycin and siRNA targeting Y-box binding protein-1 (siYB-1)
    Zeng, San
    Xiong, May P.
    BIOMATERIALS, 2013, 34 (28) : 6882 - 6892
  • [36] Nuclear shuttling of Y-box binding protein 1, its clinical relevance to cancer and as a therapeutic target
    Gunasekaran, Vinoth Prasanna
    Nishi, Kumari
    Ravikumar, Vilwanathan
    Mathan, Ganeshan
    BANGLADESH JOURNAL OF PHARMACOLOGY, 2016, 11 (02) : 501 - 524
  • [37] Tumours have a sex-relevance to the multifunctional oncoprotein Y-box binding protein-1 (YB-1)
    Croghan, S.
    Rohan, P.
    Manecksha, R. P.
    Lynch, T. H.
    Marignol, L.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S1236 - S1237
  • [38] Role of Y Box Protein-1 in cancer: As potential biomarker and novel therapeutic target
    Maurya, Pramod Kumar
    Mishra, Alok
    Yadav, Birendra Singh
    Singh, Swati
    Kumar, Prashant
    Chaudhary, Amit
    Srivastava, Shweta
    Murugesan, Suriya Narayan
    Mani, Ashutosh
    JOURNAL OF CANCER, 2017, 8 (10): : 1900 - 1907
  • [39] Y-box protein-1 is actively secreted through a non-classical pathway and acts as an extracellular mitogen
    Frye, Bjoern C.
    Halfter, Sarah
    Djudjaj, Sonja
    Muehlenberg, Philipp
    Weber, Susanne
    Raffetseder, Ute
    En-Nia, Abdelaziz
    Knott, Hanna
    Baron, Jens M.
    Dooley, Steven
    Bernhagen, Juergen
    Mertens, Peter R.
    EMBO REPORTS, 2009, 10 (07) : 783 - 789
  • [40] Activated Protein C Ameliorates Renal Ischemia-Reperfusion Injury by Restricting Y-Box Binding Protein-1 Ubiquitination
    Dong, Wei
    Wang, Hongjie
    Shahzad, Khurrum
    Bock, Fabian
    Al-Dabet, Moh'd Mohanad
    Ranjan, Satish
    Wolter, Juliane
    Kohli, Shrey
    Hoffmann, Juliane
    Dhople, Vishnu Mukund
    Zhu, Cheng
    Lindquist, Jonathan A.
    Esmon, Charles T.
    Groene, Elisabeth
    Groene, Herman-Josef
    Madhusudhan, Thati
    Mertens, Peter R.
    Schlueter, Dirk
    Isermann, Berend
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2015, 26 (11): : 2789 - 2799
12345